Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin M Balko

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: <i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
The Oncologist|August 14, 2021
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer CenterNeha M Jain, Lauren Schmalz, Christopher Cann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Cancer Research|November 11, 2018
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1Thomas A Werfel, David L Elion, Bushra Rahman, et al.
Cancer Research|December 7, 2014
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancerNeil E Bhola, Valerie M Jansen, Sangeeta Bafna, et al.
Scientific Reports|May 10, 2017
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignanciesJoseph A Pinto, Christian Rolfo, Luis E Raez, et al.
Nature Communications|January 18, 2018
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancerNa Luo, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.
Cancer Research|February 17, 2019
Correction: Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast CancerNeil E Bhola, Valerie M Jansen, Sangeeta Bafna, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: <i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
The Oncologist|August 14, 2021
Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute-Designated Comprehensive Cancer CenterNeha M Jain, Lauren Schmalz, Christopher Cann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Cancer Research|November 11, 2018
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1Thomas A Werfel, David L Elion, Bushra Rahman, et al.
Cancer Research|December 7, 2014
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancerNeil E Bhola, Valerie M Jansen, Sangeeta Bafna, et al.
Scientific Reports|May 10, 2017
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignanciesJoseph A Pinto, Christian Rolfo, Luis E Raez, et al.
Nature Communications|January 18, 2018
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancerNa Luo, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.
Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.
Cancer Research|February 17, 2019
Correction: Kinome-wide Functional Screen Identifies Role of PLK1 in Hormone-Independent, ER-Positive Breast CancerNeil E Bhola, Valerie M Jansen, Sangeeta Bafna, et al.
Pageof 18